IMMUNOHISTOCHEMISTRY, EPITHELIAL MEMBRANE ANTIGEN (EMA)

The IHC – EMA (Epithelial Membrane Antigen) test is an immunohistochemistry-based diagnostic test used to detect EMA protein expression in tissue samples. EMA is a glycoprotein commonly expressed on the surface of epithelial cells and is widely used as a tumor marker in pathology.

This test plays an important role in identifying and classifying epithelial-origin tumors (carcinomas) as well as certain non-epithelial tumors like meningiomas and plasma cell neoplasms. EMA helps pathologists differentiate between benign and malignant lesions and determine the tissue of origin of tumors.

Benefits of the Test

• Helps identify epithelial-origin tumors (carcinomas)
• Assists in diagnosing meningiomas and plasma cell tumors
• Improves tumor classification accuracy
• Differentiates epithelial tumors from lymphomas and sarcomas
• Supports cancer staging and treatment planning

Why Doctors Recommend This Test

Doctors recommend the IHC EMA test when there is suspicion of poorly differentiated tumors or unclear tissue origin. It is commonly used in:

• Carcinoma diagnosis (lung, breast, gastrointestinal, etc.)
• Brain tumor evaluation (especially meningioma)
• Soft tissue tumor classification
• Differentiation of carcinoma vs lymphoma vs sarcoma
• Oncology biopsy evaluation

EMA is often used in combination with other markers such as cytokeratins (CK), vimentin, S100, and CD markers to achieve accurate tumor identification.

Preparation Before Test

No special preparation is required from the patient. Important notes:

• The test is performed on biopsy or surgical tissue samples
• No fasting or medication restrictions are required
• Clinical history and imaging findings help improve interpretation

Normal Reporting Time

The test typically takes 3 to 5 working days, depending on laboratory workload and sample complexity.

Who Should Take This Test

• Patients with suspected carcinoma
• Individuals with brain tumors like meningioma
• Cases of undifferentiated malignancy
• Soft tissue tumor evaluations
• Oncology biopsy diagnosis and staging cases

The IHC EMA test is a vital tool in modern diagnostic pathology. It helps identify epithelial differentiation in tumors, ensuring accurate classification and guiding appropriate cancer treatment strategies.